Involvement of glycogen synthase kinase-3ß and oxidation status in the loss of cardioprotection by postconditioning in chronic diabetic male rats

Advanced Pharmaceutical Bulletin

Volumn 5, Issue 3, 2015, Pages 321-327

  Badalzadeh, Reza ^a   Mohammadi, Mustafa ^a   Yousefi, Bahman ^b   Faranjia, Safar ^c   Najafi, Moslem ^b   Mohammadi, Shima ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardioprotection; GSK 3 , Diabetes; Postconditioning; Reperfusion injury

Indexed keywords

GLUTATHIONE; GLYCOGEN SYNTHASE KINASE 3BETA; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; HEART MUSCLE; HEART PERFUSION; HEART PROTECTION; ISCHEMIC POSTCONDITIONING; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT;

EID: 84983575308     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.15171/apb.2015.045     Document Type: Article

References (30)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 2013;127(1):e6-e245.
2. Whittington HJ, Babu GG, Mocanu MM, Yellon DM, Hausenloy DJ. The diabetic heart: too sweet for its own good? Cardiol Res Pract 2012;2012:845698. doi: 10.1155/2012/845698.
3. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285(2):H579-88. doi: 10.1152/ajpheart.01064.2002.
4. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007;59(4):418-58. doi: 10.1124/pr.107.06002.
5. Kharbanda RK. Cardiac conditioning: a review of evolving strategies to reduce ischaemia-reperfusion injury. Heart 2010;96(15):1179-86. doi: 10.1136/hrt.2009.179101.
6. Lacerda L, Somers S, Opie LH, Lecour S. Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Cardiovasc Res 2009;84(2):201-8. doi: 10.1093/cvr/cvp274.
7. Wagner C, Kloeting I, Strasser RH, Weinbrenner C. Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: role of glycogen synthase kinase 3beta. J Cardiovasc Pharmacol 2008;52(5):430-7. doi: 10.1097/fjc.0b013e31818c12a7.
8. Miki T, Itoh T, Sunaga D, Miura T. Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning. Cardiovasc Diabetol 2012;11:67. doi: 10.1186/1475-2840-11-67.
9. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999;100(10):1134-46. doi: 10.1161/01.cir.100.10.1134.
10. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001;37(4):1053-9. doi: 10.1161/01.hyp.37.4.1053.
11. Sanada S, Komuro I, Kitakaze M. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol 2011;301(5):H1723-41. Doi: 10.1152/ajpheart.00553.2011.
12. Gomez L, Paillard M, Thibault H, Derumeaux G, Ovize M. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 2008;117(21):2761-8. doi: 10.1161/circulationaha.107.755066.
13. Xi J, Wang H, Mueller RA, Norfleet EA, Xu Z. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore. Eur J Pharmacol 2009;604(1-3):111-6. doi: 10.1016/j.ejphar.2008.12.024.
14. Juhaszova M, Zorov DB, Yaniv Y, Nuss HB, Wang S, Sollott SJ. Role of glycogen synthase kinase-3beta in cardioprotection. Circ Res 2009;104(11):1240-52. doi: 10.1161/circresaha.109.197996.
15. Nishihara M, Miura T, Miki T, Tanno M, Yano T, Naitoh K, et al. Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. J Mol Cell Cardiol 2007;43(5):564-70. doi: 10.1016/j.yjmcc.2007.08.010.
16. Kaminski KA, Bonda TA, Korecki J, Musial WJ. Oxidative stress and neutrophil activation--the two keystones of ischemia/reperfusion injury. Int J Cardiol 2002;86(1):41-59. doi: 10.1016/s0167-5273(02)00189-4.
17. Zhai P, Sciarretta S, Galeotti J, Volpe M, Sadoshima J. Differential roles of GSK-3beta during myocardial ischemia and ischemia/reperfusion. Circ Res 2011;109(5):502-11. doi: 10.1161/circresaha.111.249532.
18. Badalzadeh R, Mohammadi M, Najafi M, Ahmadiasl N, Farajnia S, Ebrahimi H. The additive effects of ischemic postconditioning and cyclosporine-A on nitric oxide activity and functions of diabetic myocardium injured by ischemia/reperfusion. J Cardiovasc Pharmacol Ther 2012;17(2):181-9. doi: 10.1177/1074248411416118.
19. Yun Y, Duan WG, Chen P, Wu HX, Shen ZQ, Qian ZY, et al. Ischemic postconditioning modified renal oxidative stress and lipid peroxidation caused by ischemic reperfusion injury in rats. Transplant Proc 2009;41(9):3597-602. doi: 10.1016/j.transproceed.2009.06.203.
20. Przyklenk K, Maynard M, Greiner DL, Whittaker P. Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxid Redox Signal 2011;14(5):781-90. doi: 10.1089/ars.2010.3343.
21. Gross ER, Hsu AK, Gross GJ. Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase- ta. Diabetes 2007;56(1):127-36. doi: 10.2337/db06-0907.
22. Drenger B, Ostrovsky IA, Barak M, Nechemia-Arbely Y, Ziv E, Axelrod JH. Diabetes blockade of sevoflurane postconditioning is not restored by insulin in the rat heart: phosphorylated signal transducer and activator of transcription 3- and phosphatidylinositol 3-kinase-mediated inhibition. Anesthesiology 2011;114(6):1364-72. doi: 10.1097/ALN.0b013e31820efafd.
23. Ansley DM, Wang B. Oxidative stress and myocardial injury in the diabetic heart. J Pathol 2013;229(2):232-41. doi: 10.1002/path.4113.
24. Fan Q, Yang XC, Liu Y, Wang LF, Liu SH, Ge YG, et al. Postconditioning attenuates myocardial injury by reducing nitro-oxidative stress in vivo in rats and in humans. Clin Sci (Lond) 2011;120(6):251-61. doi: 10.1042/CS20100369.
25. Zhao ZQ, Vinten-Johansen J. Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res 2006;70(2):200-11. doi: 10.1016/j.cardiores.2006.01.024 26.
26. Vaez H, Samadzadeh M, Zahednezhad F, Najafi M. Resistance to reperfusion injury following short term postischemic administration of natural honey in globally ischemic isolated rat heart. Adv Pharm Bull 2012;2(2):189-96. doi: 10.5681/apb.2012.029
27. Badalzadeh R, Yousefi B, Majidinia M, Ebrahimi H. Anti-arrhythmic effect of diosgenin in reperfusion-induced myocardial injury in a rat model: activation of nitric oxide system and mitochondrial KATP channel. J Physiol Sci 2014;64(6):393-400. doi: 10.1007/s12576-014-0333-8
28. Rodrigo R, Prieto JC, Castillo R. Cardioprotection against ischaemia/reperfusion by vitamins C and E plus n-3 fatty acids: molecular mechanisms and potential clinical applications. Clin Sci (Lond) 2013;124(1):1-15. doi: 10.1042/cs20110663.
29. Ebrahimi H, Badalzadeh R, Mohammadi M, Yousefi B. Diosgenin attenuates inflammatory response induced by myocardial reperfusion injury: role of mitochondrial ATP-sensitive potassium channels. J Physiol Biochem 2014;70(2):425-32. doi: 10.1007/s13105-014-0320-9.
30. Kumar M, Sharma S, Vasudeva N. In vivo assessment of antihyperglycemic and antioxidant activity from oil of seeds of brassica nigra in streptozotocin induced diabetic rats. Adv Pharm Bull 2013;3(2):359-65. doi: 10.5681/apb.2013.058.